83 related articles for article (PubMed ID: 7790254)
21. Conservative surgery in T3-T4 pharyngolaryngeal squamous cell carcinoma: an alternative to radiation therapy and to total laryngectomy for good responders to induction chemotherapy.
Lecanu JB; Monceaux G; Périé S; Angelard B; St Guily JL
Laryngoscope; 2000 Mar; 110(3 Pt 1):412-6. PubMed ID: 10718429
[TBL] [Abstract][Full Text] [Related]
22. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
[TBL] [Abstract][Full Text] [Related]
23. Radiosensitization of Ras-mutated human tumor cells in vitro by the specific EGF receptor antagonist BIBX1382BS.
Toulany M; Dittmann K; Baumann M; Rodemann HP
Radiother Oncol; 2005 Feb; 74(2):117-29. PubMed ID: 15734199
[TBL] [Abstract][Full Text] [Related]
24. [Proteasome inhibitor bortezomib sensitizes Hep-2 human laryngeal squamous cell carcinoma cells to ionizing radiation in vitro and in vivo].
Wang QW; Liu H; Liang YM; Wang T; Zhu XD
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Jun; 43(6):456-9. PubMed ID: 18826102
[TBL] [Abstract][Full Text] [Related]
25. Results of treatment of inoperable recurrences of laryngeal cancer after total laryngectomy.
Sas-Korczyńska B; Korzeniowski S; Skolyszewski J
Strahlenther Onkol; 1996 Feb; 172(2):99-102. PubMed ID: 8669051
[TBL] [Abstract][Full Text] [Related]
26. [Synergistic effects and mechanisms of combined tumor necrosis factor-related apoptosis-inducing ligand and chemotherapeutic drugs or radiotherapy in killing laryngeal squamous carcinoma cells in vitro].
Zhang M; Zhou L
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Jul; 44(7):565-70. PubMed ID: 19957654
[TBL] [Abstract][Full Text] [Related]
27. Recovery from sublethal damage during fractionated irradiation of human FaDu SCC.
Petersen C; Zips D; Krause M; Völkel W; Thames HD; Baumann M
Radiother Oncol; 2005 Mar; 74(3):331-6. PubMed ID: 15763315
[TBL] [Abstract][Full Text] [Related]
28. Downregulation of RhoB GTPase confers resistance to cisplatin in human laryngeal carcinoma cells.
Cimbora-Zovko T; Fritz G; Mikac N; Osmak M
Cancer Lett; 2010 Sep; 295(2):182-90. PubMed ID: 20303648
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of Raf-1 protein kinase by antisense phosphorothioate oligodeoxyribonucleotide is associated with sensitization of human laryngeal squamous carcinoma cells to gamma radiation.
Soldatenkov VA; Dritschilo A; Wang FH; Olah Z; Anderson WB; Kasid U
Cancer J Sci Am; 1997; 3(1):13-20. PubMed ID: 9072302
[TBL] [Abstract][Full Text] [Related]
30. [Time factor and repopulation during fractionated radiotherapy. Comparison between two xenografted human squamous cell carcinoma].
Hesselmann S; Lindel K; Horn K; Könemann S; Schuck A; Willich N; Rübe C
Strahlenther Onkol; 2003 Jan; 179(1):38-44. PubMed ID: 12540983
[TBL] [Abstract][Full Text] [Related]
31. Monitoring PAI-1 and VEGF levels in 6 human squamous cell carcinoma xenografts during fractionated irradiation.
Bayer C; Kielow A; Schilling D; Maftei CA; Zips D; Yaromina A; Baumann M; Molls M; Multhoff G
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):e409-17. PubMed ID: 22687194
[TBL] [Abstract][Full Text] [Related]
32. Radiation-induced cell death is independent of the apoptotic signals mediated by death-associated protein kinase in human cervical squamous cell carcinoma cells.
Tanaka T; Bai T; Yukawa K; Umesaki N
Oncol Rep; 2005 Oct; 14(4):949-55. PubMed ID: 16142356
[TBL] [Abstract][Full Text] [Related]
33. Differentiation of squamous carcinoma of the larynx as a determinant of prognosis.
Michaels L
Can J Otolaryngol; 1975; 4(5):873-80. PubMed ID: 54205
[TBL] [Abstract][Full Text] [Related]
34. De novo cisplatinum resistance does not influence cellular radiosensitivity.
Britten RA; Warenius HM
Eur J Cancer; 1993; 29A(9):1315-20. PubMed ID: 8343276
[TBL] [Abstract][Full Text] [Related]
35. Application of primary cell cultures of laryngeal carcinoma and laser scanning cytometry in the evaluation of tumor reactivity to cisplatinum.
Klatka J; Paduch R; Pozarowski P; Pietruszewska W; Kupisz K; Trojanowski P; Roliński J
Folia Histochem Cytobiol; 2008; 46(2):159-64. PubMed ID: 18519232
[TBL] [Abstract][Full Text] [Related]
36. [Chemotherapy guidance of the drug sensitivity test in vitro in human laryngeal squamous cell carcinoma].
Zhang S; Kong W
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Aug; 20(15):711-3. PubMed ID: 17037023
[TBL] [Abstract][Full Text] [Related]
37. Expression of collateral sensitivity to cisplatin, methotrexate, and fluorouracil in a human ovarian carcinoma cell line following exposure to fractionated x-irradiation in vitro.
Dempke WC; Hosking LK; Hill BT
Semin Oncol; 1992 Apr; 19(2 Suppl 3):66-72. PubMed ID: 1557659
[TBL] [Abstract][Full Text] [Related]
38. Squamous cell carcinoma is highly sensitive to taxol, a possible new radiation sensitizer.
Elomaa L; Joensuu H; Kulmala J; Klemi P; Grénman R
Acta Otolaryngol; 1995 Mar; 115(2):340-4. PubMed ID: 7610837
[TBL] [Abstract][Full Text] [Related]
39. Cisplatin reduces epidermal growth factor receptors in squamous-cell carcinoma in vitro. Preliminary results.
Bergler W; Bier H
ORL J Otorhinolaryngol Relat Spec; 1990; 52(5):297-302. PubMed ID: 2234901
[TBL] [Abstract][Full Text] [Related]
40. Pre-exposure of human squamous carcinoma cells to low-doses of gamma-rays leads to an increased resistance to subsequent low-dose cisplatin treatment.
Caney C; Bulmer JT; Singh G; Lukka H; Rainbow AJ
Int J Radiat Biol; 1999 Aug; 75(8):963-72. PubMed ID: 10465362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
